Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine.

Brain and Spinal Injury Center, University of California, San Francisco, CA, USA.
Brain (Impact Factor: 10.23). 07/2009; 132(Pt 9):2464-77. DOI: 10.1093/brain/awp148
Source: PubMed

ABSTRACT Understanding how the hippocampus processes episodic memory information during neuropathological conditions is important for treatment and prevention applications. Previous data have shown that during chronic neuroinflammation the expression of the plasticity related behaviourally-induced immediate early gene Arc is altered within the CA3 and the dentate gyrus; both of these hippocampal regions show a pronounced increase in activated microglia. Low doses of memantine, a low to moderate affinity open channel uncompetitive N-Methyl-d-aspartate receptor antagonist, reduce neuroinflammation, return Arc expression to control levels and attenuate cognitive deficits induced by lipopolysaccharide. Here we investigate whether neuroinflammation affects the accuracy of information processing in the CA3 and CA1 hippocampal regions and if this is modified by memantine treatment. Using the immediate early gene-based brain-imaging method called cellular analysis of temporal activity by fluorescence in situ hybridization, it is possible to detect primary transcripts at the genomic alleles; this provides exceptional temporal and cellular resolution and facilitates the mapping of neuronal activity. Here, we use this method to compare the neuronal populations activated by two separate experiences in CA1 and CA3 and evaluate the accuracy of information processing during chronic neuroinflammation. Our results show that the CA3 pyramidal neuron activity is not stable between two exposures to the same environment context or two different contexts. CA1 networks, however, do not differ from control conditions. These data suggest that during chronic neuroinflammation, the CA3 networks show a disrupted ability to encode spatial information, and that CA1 neurons can work independently of CA3. Importantly, memantine treatment is able to partially normalize information processing in the hippocampus, suggesting that when given early during the development of the pathology memantine confers neuronal and cognitive protection while indirectly prevents pathological microglial activation.

Download full-text


Available from: Victor Ramírez-Amaya, Feb 06, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Response reversal learning is facilitated in many species, including humans, when competing responses occur in separate contexts. This suggests hippocampal maps may facilitate the acquisition of competing responses and is consistent with the hypothesis that contextual encoding permits rapid acquisition of new behaviors in similar environments. To test this hypothesis, the pattern of Arc expression was examined after rats completed a series of left/right response reversals in a T-maze. This reversal training occurred in the same room, two different rooms, or within a single room but with the maze enclosed in wall-length curtains of different configurations (i.e., black/white square or circle). Across CA1 and CA3, successive T-maze exposures in the same room recruited the same cells to repeatedly transcribe Arc, while a unique population of cells transcribed Arc in response to each of two different rooms as well as to the two unique curtain configurations in the same room. The interference from original learning that was evident on the first reversal in animals without a context switch was absent in groups that experienced changes in room or curtain configuration. However, only the use of unique rooms, and not changes in the curtained enclosure, facilitated learning across response reversals relative to the groups exposed to only one room. Thus, separate hippocampal maps appear to provide protection from the original learning interference but do not support improved reversals over trials. The present data suggest changes in heading direction input, rather than remapping, are the source of facilitation of reversal learning. © 2013 Wiley Periodicals, Inc.
    Hippocampus 04/2014; 24(4). DOI:10.1002/hipo.22233 · 4.30 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Proinflammatory stimuli evoke an export of glutamate from microglia that is sufficient to contribute to excitotoxicity in neighboring neurons. Because microglia also express various glutamate receptors themselves, we were interested in the potential feedback of glutamate on this system. Several agonists of metabotropic glutamate receptors (mGluR) were applied to primary rat microglia, and the export of glutamate into their culture medium was evoked by lipopolysaccharide (LPS). Agonists of group-II and -III mGluRs (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD) and L-(+)-2-amino-4-phosphonobutyric acid (L-AP4) were both capable of completely blocking the glutamate export without interfering with the production of nitric oxide; the group-I agonist trans-azetidine-2,4-dicarboxylic acid (tADA) was ineffective. Consistent with the possibility of feedback, inhibition of mGluRs by (R,S)-alpha-2-methyl-4sulphonophenylglycine (MSPG) potentiated glutamate export. As the group-II and -III mGluRs are coupled to Gαi-containing G-proteins and the inhibition of adenylate cyclase, we explored the role of cyclic AMP (cAMP) in this effect. Inhibition of cAMP-dependent protein kinase by H89 mimicked the effect of ACPD, and the mGluR agonist had its actions reversed by artificially sustaining cAMP through the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) or the cAMP mimetic dibutyryl-cAMP. These data indicate that mGluR activation attenuates a potentially neurotoxic export of glutamate from activated microglia and implicate cAMP as a contributor to this aspect of microglial actions.
    ASN Neuro 07/2012; 4(5). DOI:10.1042/AN20120044 · 4.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As an antidiabetic agent, rosiglitazone (ROSI) binds and activates peroxisome proliferator-activator receptor gamma (PPARγ), altering the expression of genes involved in glucose uptake and disposal, ultimately affecting glucose regulation. ROSI might therefore be a potential treatment to ameliorate age-related decline in cognitive function, particularly on an insulin-resistant background, where improvements in peripheral insulin sensitivity and central nervous system (CNS) glucose utilization may facilitate recovery of cognitive function. We therefore examined the amelioration potential of ROSI for neurocognitive deficits resulting from aging in an animal model. Behaviorally, acute and chronic ROSI treatments enhanced acquisition of learning in the water plus maze, a modified version of the Morris water maze task. In parallel, restoration of synaptic plasticity in the dentate gyrus of ROSI-treated middle-aged rats was evident after a single dose intake. Additionally, the spatial receptive fields of hippocampal CA1 place cells were significantly improved by chronic ROSI administration. ROSI treatment reversed basal plasma insulin abnormalities and increased hippocampal glucose transporter (GLUT)-3 expression in middle-aged rats. Taken together, these results suggest that ROSI modulates hippocampal circuitry effectively to promote an improvement in cognitive function, possibly via a glucose transporter-3 mechanism.
    Neurobiology of aging 04/2012; 33(4):835.e13-30. DOI:10.1016/j.neurobiolaging.2011.08.013 · 4.85 Impact Factor